| Literature DB >> 33034557 |
Jessica Olson1, Tobi Cawthra2, Kirsten Beyer2, David Frazer3, Lyle Ignace4, Cheryl Maurana2, Sandra Millon-Underwood5, Laura Pinsoneault6, Jose Salazar7, Alonzo Walker2, Carol Williams2, Melinda Stolley2.
Abstract
INTRODUCTION: Significant disparities are apparent in geographic areas and among racial/ethnic minority groups in Wisconsin. Cancer disparities are complex and multifactorial and require collaborative, multilevel efforts to reduce their impact. Our objective was to understand cancer disparities and identify opportunities to collaborate across community and research sectors to address them.Entities:
Mesh:
Year: 2020 PMID: 33034557 PMCID: PMC7553208 DOI: 10.5888/pcd17.200183
Source DB: PubMed Journal: Prev Chronic Dis ISSN: 1545-1151 Impact factor: 2.830
Figure 1Female breast cancer mortality rate (Map A) and lung cancer mortality rate (Map B), Wisconsin, 2008–2013. The female breast cancer mortality rate is indirectly age standardized and smoothed using adaptive spatial filtering. The lung cancer mortality rate is indirectly age–sex standardized and smoothed using adaptive spatial filtering. A grid of points is used to estimate mortality rates continuously across the map, based on the 20 closest breast cancer deaths and the 40 closest lung cancer deaths. Red areas indicate higher rates than expected and blue areas indicate lower rates than expected, compared with the regional rate. Areas without color indicate rates close to the regional rate. Data source: State Vital Records Office, Wisconsin Department of Health Services 2008-2013 (12). Reprinted with permission of Yuhong Zhou, PhD, and Kirsten Beyer, PhD, MPH, MS, Medical College of Wisconsin.
Demographic Characteristics, Wisconsin and 7 Participating Counties, Community and Research Perspectives on Cancer Disparities, May 2017–October 2018
| Characteristic | Wisconsin | County | ||||||
|---|---|---|---|---|---|---|---|---|
| Marinette | Milwaukee | Oconto | Oneida | Racine | Vilas | Walworth | ||
|
| 5,813,434 | 40,434 | 948,207 | 37,830 | 35,470 | 196,584 | 21,938 | 103,718 |
|
| 59,209 | 47,497 | 48,742 | 57,105 | 54,198 | 59,749 | 44,285 | 61,106 |
|
| 11.0 | 12.0 | 19.1 | 9.2 | 9.4 | 12.6 | 10.9 | 10.1 |
|
| 6.5 | 6.2 | 8.1 | 6.3 | 6.3 | 6.2 | 10.2 | 8.5 |
|
| ||||||||
| White | 81.1 | 95.1 | 51.0 | 94.8 | 94.7 | 71.7 | 84.8 | 85.3 |
| Black | 6.7 | 0.6 | 27.2 | 0.4 | 0.7 | 12.0 | 0.4 | 1.2 |
| American Indian | 1.2 | 0.8 | 1.0 | 1.5 | 1.2 | 0.7 | 11.1 | 1.1 |
| Hispanic/Latino | 6.9 | 1.9 | 15.4 | 1.8 | 1.6 | 13.4 | 2.8 | 11.2 |
|
| ||||||||
| Age adjusted incidence rate per 100,000 | 68.0 | 62.0 | 74.6 | 63.4 | 78.7 | 69.7 | 74.0 | 68.6 |
| Late-stage diagnosis, % of total cases | 32.5 | 37.2 | 35.6 | 36.9 | 37.3 | 34.4 | 27.5 | 32.2 |
| Age adjusted mortality rate per 100,000 | 10.7 | 9.8 | 11.9 | 11.7 | 9.8 | 10.4 | 10.7 | 11.0 |
|
| ||||||||
| Age adjusted incidence rate per 100,000 | 59.8 | 69.8 | 69.1 | 64.6 | 74.6 | 68.7 | 72.0 | 60.0 |
| Late-stage diagnosis, % of total cases | 74.3 | 78.7 | 77.0 | 86.0 | 87.6 | 74.5 | 84.3 | 77.0 |
| Age adjusted mortality rate per 100,000 | 41.0 | 48.9 | 46.6 | 46.1 | 48.3 | 44.9 | 41.1 | 45.6 |
Age adjusted to 2000 US standard population.
Listening Session and Interview Questions Asked and Participant (N = 205) Characteristics, Community and Research Perspectives on Cancer Disparities, May 2017–October 2018
| Listening Session and Interview Format | Justification |
|---|---|
|
| |
| Homogeneous | Create an environment where groups feel comfortable sharing experiences. |
| Facilitated | Enable open conversation that respects cultural, racial/ethnic, or research identities. |
| Transparent | Ensure the intentions of data collection are clear, and participants understand their ability to stay informed and continue to give feedback throughout the project. |
| Valid | Seek feedback from a representative from each community after compilation of data, and make modifications, additions, or redactions before dissemination. |
| Respectful | Establish at the beginning of each listening session or interview that all opinions are valid, and all participants may finish their thoughts without interruption. |
| Flexible | Tailor sessions to be responsive to participant needs, including group size, style, language, format, and familiarity with the topic of cancer disparities. |
|
|
|
| Research: How would you describe the health of Wisconsin communities? Community: How would you describe the health of your community? | Research: Rank the health of Wisconsin communities and explain. Community: Rank the health of your community and explain. (A = Excellent, F = Terrible) |
| If money or resources were no issue, what would you do to improve cancer disparities? | Are there assumptions that people make about (your community/research)? |
| Why do maps of breast and lung cancer incidence and mortality look the way that they do? | Are there things that surprise you or don’t surprise you? |
|
|
|
| Biologic contributors | Genetic predisposition |
| Research needs | Better cancer detection, availability of samples from different populations, funding |
| Behaviors and comorbidities | Obesity, poverty, alcoholism, smoking, diet, exercise, stress, reproductive factors, breastfeeding, use of hormone replacement therapy |
| Demographic factors | Health literacy, gender, race/ethnicity, childhood education |
| Geographic location | Distance to care, location of care, availability of transportation |
| Environment | Airborne, housing, and workplace exposures, radon, water quality |
| Social conditions | Social isolation, cultural norms, social support |
| Institutional barriers | Availability of quality care, patient support, availability of partnerships and funding sources, medical mistrust |
| Policy issues | Insurance coverage, societal poverty, generic drug availability, adherence to policy |
Topics Discussed in Listening Sessions and Interviews, Community and Research Perspectives on Cancer Disparities, May 2017–October 2018a
| Topic of Discussion | Research Participants | Community Participants (n = 158) | |
|---|---|---|---|
| Basic/Clinical (n = 36) | Population Health (n = 11) | ||
|
| |||
| Availability of technology, samples, and models | X | ||
| Genetic predisposition | X | X | X |
| Mechanisms of protection or damage | X | ||
|
| |||
| Alcohol, obesity, and stress | X | X | X |
|
| |||
| Medical mistrust, delay to diagnosis, completion, adherence to care | X | X | X |
| Reproductive/gynecologic factors | X | X | |
| Individual diet, alcohol, tobacco, and illegal drug use | X | X | X |
|
| |||
| Access to care | X | X | |
| Childhood and community education | X | X | |
| Cultural and acculturation | X | X | |
| Gender and race | X | X | X |
| Employment and socioeconomic status | X | X | |
|
| |||
| Environment (agriculture, home, community, workplace exposures) | X | X | X |
| Location (urban, rural, green, isolated) | X | X | X |
|
| |||
| Acceptability of alcohol consumption and smoking | X | X | X |
| Social factors (support, isolation, pride, self-efficacy) | X | X | |
|
| |||
| Effectiveness of partnerships | X | X | X |
| Social capital | X | X | X |
|
| |||
| Adequate patient support, care, and physician training | X | X | X |
| Capacity for multidisciplinary work | X | X | |
| Guideline concordant care, hospital volume, cancer detection | X | ||
| Need for champions and funding opportunities | X | X | |
|
| |||
| Environment, housing, and insurance-based policy | X | X | |
| Insurance issues | X | X | |
| Social inequality and societal poverty | X | X | X |
X indicates that the topic was discussed in the basic/clinical research, population health research, and/or community groups.
Figure 2Composition of listening sessions and interviews. A total of 205 participants answered semistructured questions about communities and cancer disparities in Wisconsin. Sixty-seven participants represented basic, population health, and clinical research, and 138 participants represented community perspectives. We also conducted a listening session at a coordinators meeting of Well Woman, the Wisconsin’s Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program.